PubRank

Roberto I Troisi

Author PubWeight™ 18.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg 2015 2.36
2 Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation 2016 1.59
3 Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values. Liver Transpl 2013 1.41
4 International experience for laparoscopic major liver resection. J Hepatobiliary Pancreat Sci 2014 1.23
5 A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer 2010 1.06
6 A multicentre, randomized clinical trial comparing the Veriset™ haemostatic patch with fibrin sealant for the management of bleeding during hepatic surgery. HPB (Oxford) 2012 0.85
7 Impact of surgical margins on overall and recurrence-free survival in parenchymal-sparing laparoscopic liver resections of colorectal metastases. Surg Endosc 2014 0.82
8 Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation. Eur J Gastroenterol Hepatol 2013 0.82
9 Resection of single metachronous liver metastases from breast cancer stage I-II yield excellent overall and disease-free survival. Single center experience and review of the literature. Dig Surg 2015 0.81
10 Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience. Clin Transplant 2015 0.81
11 Living related liver transplantation in an adult patient with hepatocellular adenoma and carcinoma 13 years after bone marrow transplantation for Fanconi anemia: A case report. Hepatol Res 2013 0.79
12 Absence of viable HCC in the native liver is an independent protective factor of tumor recurrence after liver transplantation. Transplantation 2014 0.78
13 Safety analysis of the oncological outcome after vein-preserving surgery for colorectal liver metastases detached from the main hepatic veins. Langenbecks Arch Surg 2015 0.77
14 Biomarkers for the diagnosis of acute cellular rejection in liver transplant recipients: A review. Hepatol Res 2012 0.77
15 Laparoscopic Living Donor Left Lateral Sectionectomy: A New Standard Practice for Donor Hepatectomy. Ann Surg 2015 0.77
16 Organ donation in Belgium 2010: an increase of combined organ transplants and living donor liver transplantations. Transplant Proc 2011 0.76
17 Tissue management with tri-staple technology in major and minor laparoscopic liver resections. Int Surg 2014 0.76
18 Defining Benchmarks for Major Liver Surgery: A multicenter Analysis of 5202 Living Liver Donors. Ann Surg 2016 0.75
19 Prevalence and outcome of diastolic dysfunction in liver transplantation recipients. Acta Cardiol 2014 0.75
20 Successful transplantation of small-for-size grafts: a reappraisal. Liver Transpl 2012 0.75
21 Conversion for Unfavorable Intraoperative Events Results in Significantly Worst Outcomes During Laparoscopic Liver Resection: Lessons Learned From a Multicenter Review of 2861 Cases. Ann Surg 2017 0.75
22 Cisplatin-modified de Gramont in second-line therapy for pancreatic adenocarcinoma. Pancreas 2013 0.75
23 Expert Panel Statement on Laparoscopic Living Donor Hepatectomy. Dig Surg 2017 0.75
24 Survey Results of the Expert Meeting on Laparoscopic Living Donor Hepatectomy and Literature Review. Dig Surg 2017 0.75
25 Laparoscopic Versus Open Liver Resection For Colorectal Metastases in Elderly and Octogenarian Patients: A Multicenter Propensity Score Based Analysis of Short- and Long-term Outcomes. Ann Surg 2017 0.75